Please use this identifier to cite or link to this item: https://www.um.edu.mt/library/oar/handle/123456789/88492
Title: Therapeutic drug monitoring of lamotrigine in a paediatric population
Authors: Mifsud, Janet
Shabbi, H.
Soler, D.
Keywords: Drug monitoring
Drug interactions
Lamotrigine
Epilepsy in children
Anticonvulsants
Issue Date: 2006-12
Publisher: John Wiley & Sons, Inc.
Citation: Mifsud, J., Shabbi, H., & Soler, D. (2006). Therapeutic drug monitoring of lamotrigine in a paediatric population. Epilepsia, 47(s3), 124-125.
Abstract: PURPOSE: Therapeutic drug monitoring is important for drugs that exhibit interindividual variability in pharmacokinetics, and where drug-drug interactions, concurrent disease or age alters the kinetics of that drug. This is of particular importance in a chronic neurological condition such as epilepsy. In this study, the value of therapeutic drug monitoring for lamotrigine, a novel antiepileptic drug, was investigated in a group of paediatric patients.
METHOD: Plasma lamotrigine levels in 20 paediatric patients (mean ±S.D., age 8.85±3.47 years and weight, 32.22±20.81 kg) were measured using a novel validated high performance liquid chromatography (HPLC) technique that gave a retention time for lamotrigine and internal standard of 1.258 min and 2.30 min respectively. The method proved to be linear, precise and reproducible over the plasma concentration range of 0.08–20mg/.
[excerpt]
URI: https://www.um.edu.mt/library/oar/handle/123456789/88492
Appears in Collections:Scholarly Works - FacM&SCPT

Files in This Item:
File Description SizeFormat 
Therapeutic drug monitoring of lamotrigine in a paediatric population.pdf
  Restricted Access
48.3 kBAdobe PDFView/Open Request a copy


Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.